Related Experiment Videos
Microtubules and actin filaments: dynamic targets for cancer chemotherapy
1Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara 93106-9610, USA. jordan@lifesci.lscf.ucsb.edu
Abstract:
Microtubules and actin filaments play important roles in mitosis, cell signaling, and motility. Thus these cytoskeletal filaments are the targets of a growing number of anti-cancer drugs. In this review we summarize the current understanding of the mechanisms of these drugs in relation to microtubule and actin filament polymerization and dynamics. In addition, we outline how, by targeting microtubules, drugs inhibit cell proliferation by blocking mitosis at the mitotic checkpoint and inducing apoptosis. The beta-tubulin isotype specificities of new anticancer drugs and the antitumor potential of agents that act on the actin cytoskeleton are also discussed.
Insights
This review details how anti-cancer drugs targeting microtubules and actin filaments disrupt cell division and induce apoptosis. It highlights drug mechanisms, focusing on polymerization, dynamics, and the mitotic checkpoint for cancer therapy.
Area of Science:
- Cell Biology
- Pharmacology
- Oncology
Background:
- Microtubules and actin filaments are crucial cytoskeletal components involved in vital cellular processes like mitosis, signaling, and motility.
- Dysregulation of these cytoskeletal elements is a hallmark of cancer, making them attractive targets for anti-cancer drug development.
Purpose of the Study:
- To review the mechanisms of anti-cancer drugs that target microtubule and actin filament polymerization and dynamics.
- To elucidate how these drugs inhibit cancer cell proliferation by interfering with mitosis and inducing apoptosis.
- To discuss the beta-tubulin isotype specificities of novel anti-cancer agents and the potential of actin-targeting drugs.
Main Methods:
- Literature review of current research on anti-cancer drugs targeting cytoskeletal dynamics.
- Analysis of drug mechanisms related to microtubule and actin filament polymerization and dynamics.
- Examination of drug-induced mitotic arrest, checkpoint activation, and apoptosis.
Main Results:
- Drugs targeting microtubules inhibit cell proliferation by blocking mitosis at the mitotic checkpoint, leading to apoptosis.
- New anti-cancer drugs exhibit specificities towards beta-tubulin isotypes, influencing their efficacy.
- Agents acting on the actin cytoskeleton show significant antitumor potential.
Conclusions:
- Targeting microtubule and actin dynamics represents a validated strategy for anti-cancer drug development.
- Understanding isotype specificities and actin-targeting mechanisms can lead to more effective and selective cancer therapies.
- Further research into these cytoskeletal targets promises novel therapeutic approaches for various cancers.